[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Peptide Cancer Vaccine Market Report 2017

November 2017 | 105 pages | ID: A9065B7F44FEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Peptide Cancer Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Peptide Cancer Vaccine for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Peptide Cancer Vaccine market competition by top manufacturers/players, with Peptide Cancer Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Enzo Life Science (Alexis Biotech)
  • Antigen Express
  • BioLife Science
  • Immatics Biotechnologies
  • Immune Design
  • Imugene
  • Immunomedics
  • ISA Pharmaceuticals
  • Galena Biopharma
  • Generex Biotechnology Corporation
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Therapeutic CpG Peptide-Based Cancer Vaccine
  • Personalized Neoantigen Vaccination with Synthetic Long Peptides
  • Recombinant Peptide Vaccine
  • p53. Peptide-Pulsed Dendritic Cells Cancer Vaccines
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Pancreatic Cancer
  • Gastric Cancer
  • Prostate Cancer
  • Breast Cancer
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Peptide Cancer Vaccine Market Report 2017

1 PEPTIDE CANCER VACCINE OVERVIEW

1.1 Product Overview and Scope of Peptide Cancer Vaccine
1.2 Classification of Peptide Cancer Vaccine by Product Category
  1.2.1 Asia-Pacific Peptide Cancer Vaccine Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Peptide Cancer Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Therapeutic CpG Peptide-Based Cancer Vaccine
  1.2.4 Personalized Neoantigen Vaccination with Synthetic Long Peptides
  1.2.5 Recombinant Peptide Vaccine
  1.2.6 p53. Peptide-Pulsed Dendritic Cells Cancer Vaccines
  1.2.7 Others
1.3 Asia-Pacific Peptide Cancer Vaccine Market by Application/End Users
  1.3.1 Asia-Pacific Peptide Cancer Vaccine Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Pancreatic Cancer
  1.3.3 Gastric Cancer
  1.3.4 Prostate Cancer
  1.3.5 Breast Cancer
  1.3.6 Others
1.4 Asia-Pacific Peptide Cancer Vaccine Market by Region
  1.4.1 Asia-Pacific Peptide Cancer Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Peptide Cancer Vaccine (2012-2022)
  1.5.1 Asia-Pacific Peptide Cancer Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Peptide Cancer Vaccine Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC PEPTIDE CANCER VACCINE COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Peptide Cancer Vaccine Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Peptide Cancer Vaccine Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Peptide Cancer Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Peptide Cancer Vaccine (Volume and Value) by Type
  2.2.1 Asia-Pacific Peptide Cancer Vaccine Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Peptide Cancer Vaccine Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Peptide Cancer Vaccine (Volume) by Application
2.4 Asia-Pacific Peptide Cancer Vaccine (Volume and Value) by Region
  2.4.1 Asia-Pacific Peptide Cancer Vaccine Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Peptide Cancer Vaccine Revenue and Market Share by Region (2012-2017)

3 CHINA PEPTIDE CANCER VACCINE (VOLUME, VALUE AND SALES PRICE)

3.1 China Peptide Cancer Vaccine Sales and Value (2012-2017)
  3.1.1 China Peptide Cancer Vaccine Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Peptide Cancer Vaccine Revenue and Growth Rate (2012-2017)
  3.1.3 China Peptide Cancer Vaccine Sales Price Trend (2012-2017)
3.2 China Peptide Cancer Vaccine Sales Volume and Market Share by Type
3.3 China Peptide Cancer Vaccine Sales Volume and Market Share by Application

4 JAPAN PEPTIDE CANCER VACCINE (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Peptide Cancer Vaccine Sales and Value (2012-2017)
  4.1.1 Japan Peptide Cancer Vaccine Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Peptide Cancer Vaccine Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Peptide Cancer Vaccine Sales Price Trend (2012-2017)
4.2 Japan Peptide Cancer Vaccine Sales Volume and Market Share by Type
4.3 Japan Peptide Cancer Vaccine Sales Volume and Market Share by Application

5 SOUTH KOREA PEPTIDE CANCER VACCINE (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Peptide Cancer Vaccine Sales and Value (2012-2017)
  5.1.1 South Korea Peptide Cancer Vaccine Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Peptide Cancer Vaccine Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Peptide Cancer Vaccine Sales Price Trend (2012-2017)
5.2 South Korea Peptide Cancer Vaccine Sales Volume and Market Share by Type
5.3 South Korea Peptide Cancer Vaccine Sales Volume and Market Share by Application

6 TAIWAN PEPTIDE CANCER VACCINE (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Peptide Cancer Vaccine Sales and Value (2012-2017)
  6.1.1 Taiwan Peptide Cancer Vaccine Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Peptide Cancer Vaccine Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Peptide Cancer Vaccine Sales Price Trend (2012-2017)
6.2 Taiwan Peptide Cancer Vaccine Sales Volume and Market Share by Type
6.3 Taiwan Peptide Cancer Vaccine Sales Volume and Market Share by Application

7 INDIA PEPTIDE CANCER VACCINE (VOLUME, VALUE AND SALES PRICE)

7.1 India Peptide Cancer Vaccine Sales and Value (2012-2017)
  7.1.1 India Peptide Cancer Vaccine Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Peptide Cancer Vaccine Revenue and Growth Rate (2012-2017)
  7.1.3 India Peptide Cancer Vaccine Sales Price Trend (2012-2017)
7.2 India Peptide Cancer Vaccine Sales Volume and Market Share by Type
7.3 India Peptide Cancer Vaccine Sales Volume and Market Share by Application

8 SOUTHEAST ASIA PEPTIDE CANCER VACCINE (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Peptide Cancer Vaccine Sales and Value (2012-2017)
  8.1.1 Southeast Asia Peptide Cancer Vaccine Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Peptide Cancer Vaccine Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Peptide Cancer Vaccine Sales Price Trend (2012-2017)
8.2 Southeast Asia Peptide Cancer Vaccine Sales Volume and Market Share by Type
8.3 Southeast Asia Peptide Cancer Vaccine Sales Volume and Market Share by Application

9 AUSTRALIA PEPTIDE CANCER VACCINE (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Peptide Cancer Vaccine Sales and Value (2012-2017)
  9.1.1 Australia Peptide Cancer Vaccine Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Peptide Cancer Vaccine Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Peptide Cancer Vaccine Sales Price Trend (2012-2017)
9.2 Australia Peptide Cancer Vaccine Sales Volume and Market Share by Type
9.3 Australia Peptide Cancer Vaccine Sales Volume and Market Share by Application

10 ASIA-PACIFIC PEPTIDE CANCER VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Enzo Life Science (Alexis Biotech)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Peptide Cancer Vaccine Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Enzo Life Science (Alexis Biotech) Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Antigen Express
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Peptide Cancer Vaccine Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Antigen Express Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 BioLife Science
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Peptide Cancer Vaccine Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 BioLife Science Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Immatics Biotechnologies
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Peptide Cancer Vaccine Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Immatics Biotechnologies Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Immune Design
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Peptide Cancer Vaccine Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Immune Design Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Imugene
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Peptide Cancer Vaccine Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Imugene Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Immunomedics
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Peptide Cancer Vaccine Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Immunomedics Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 ISA Pharmaceuticals
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Peptide Cancer Vaccine Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 ISA Pharmaceuticals Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Galena Biopharma
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Peptide Cancer Vaccine Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Galena Biopharma Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Generex Biotechnology Corporation
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Peptide Cancer Vaccine Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Generex Biotechnology Corporation Peptide Cancer Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview

11 PEPTIDE CANCER VACCINE MANUFACTURING COST ANALYSIS

11.1 Peptide Cancer Vaccine Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Peptide Cancer Vaccine

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Peptide Cancer Vaccine Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Peptide Cancer Vaccine Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC PEPTIDE CANCER VACCINE MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Peptide Cancer Vaccine Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Peptide Cancer Vaccine Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Peptide Cancer Vaccine Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Peptide Cancer Vaccine Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Peptide Cancer Vaccine Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Peptide Cancer Vaccine Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Peptide Cancer Vaccine Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Peptide Cancer Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Peptide Cancer Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Peptide Cancer Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Peptide Cancer Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Peptide Cancer Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Peptide Cancer Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Peptide Cancer Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Peptide Cancer Vaccine Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Peptide Cancer Vaccine Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Peptide Cancer Vaccine Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Peptide Cancer Vaccine Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Peptide Cancer Vaccine Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Peptide Cancer Vaccine
Figure Asia-Pacific Peptide Cancer Vaccine Sales Volume (K Pcs) by Type (2012-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Therapeutic CpG Peptide-Based Cancer Vaccine Product Picture
Figure Personalized Neoantigen Vaccination with Synthetic Long Peptides Product Picture
Figure Recombinant Peptide Vaccine Product Picture
Figure p53. Peptide-Pulsed Dendritic Cells Cancer Vaccines Product Picture
Figure Others Product Picture
Figure Asia-Pacific Peptide Cancer Vaccine Sales (K Pcs) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Peptide Cancer Vaccine by Application in 2016
Figure Pancreatic Cancer Examples
Table Key Downstream Customer in Pancreatic Cancer
Figure Gastric Cancer Examples
Table Key Downstream Customer in Gastric Cancer
Figure Prostate Cancer Examples
Table Key Downstream Customer in Prostate Cancer
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Peptide Cancer Vaccine Market Size (Million USD) by Region (2012-2022)
Figure China Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Market Major Players Product Sales Volume (K Pcs)(2012-2017)
Table Asia-Pacific Peptide Cancer Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Peptide Cancer Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Peptide Cancer Vaccine Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Peptide Cancer Vaccine Sales Share by Players/Suppliers
Figure Asia-Pacific Peptide Cancer Vaccine Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Peptide Cancer Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Peptide Cancer Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Peptide Cancer Vaccine Revenue Share by Players
Figure 2017 Asia-Pacific Peptide Cancer Vaccine Revenue Share by Players
Table Asia-Pacific Peptide Cancer Vaccine Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Peptide Cancer Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Peptide Cancer Vaccine by Type (2012-2017)
Figure Asia-Pacific Peptide Cancer Vaccine Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Peptide Cancer Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Peptide Cancer Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Peptide Cancer Vaccine by Type (2012-2017)
Figure Asia-Pacific Peptide Cancer Vaccine Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Peptide Cancer Vaccine Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Asia-Pacific Peptide Cancer Vaccine Sales Share by Region (2012-2017)
Figure Sales Market Share of Peptide Cancer Vaccine by Region (2012-2017)
Figure Asia-Pacific Peptide Cancer Vaccine Sales Market Share by Region in 2016
Table Asia-Pacific Peptide Cancer Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Peptide Cancer Vaccine Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Peptide Cancer Vaccine by Region (2012-2017)
Figure Asia-Pacific Peptide Cancer Vaccine Revenue Market Share by Region in 2016
Table Asia-Pacific Peptide Cancer Vaccine Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Asia-Pacific Peptide Cancer Vaccine Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Peptide Cancer Vaccine Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Peptide Cancer Vaccine Sales Market Share by Application (2012-2017)
Figure China Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Peptide Cancer Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table China Peptide Cancer Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table China Peptide Cancer Vaccine Sales Volume Market Share by Type (2012-2017)
Figure China Peptide Cancer Vaccine Sales Volume Market Share by Type in 2016
Table China Peptide Cancer Vaccine Sales Volume (K Pcs) by Applications (2012-2017)
Table China Peptide Cancer Vaccine Sales Volume Market Share by Application (2012-2017)
Figure China Peptide Cancer Vaccine Sales Volume Market Share by Application in 2016
Figure Japan Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Peptide Cancer Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Peptide Cancer Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Peptide Cancer Vaccine Sales Volume Market Share by Type (2012-2017)
Figure Japan Peptide Cancer Vaccine Sales Volume Market Share by Type in 2016
Table Japan Peptide Cancer Vaccine Sales Volume (K Pcs) by Applications (2012-2017)
Table Japan Peptide Cancer Vaccine Sales Volume Market Share by Application (2012-2017)
Figure Japan Peptide Cancer Vaccine Sales Volume Market Share by Application in 2016
Figure South Korea Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure South Korea Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Peptide Cancer Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table South Korea Peptide Cancer Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table South Korea Peptide Cancer Vaccine Sales Volume Market Share by Type (2012-2017)
Figure South Korea Peptide Cancer Vaccine Sales Volume Market Share by Type in 2016
Table South Korea Peptide Cancer Vaccine Sales Volume (K Pcs) by Applications (2012-2017)
Table South Korea Peptide Cancer Vaccine Sales Volume Market Share by Application (2012-2017)
Figure South Korea Peptide Cancer Vaccine Sales Volume Market Share by Application in 2016
Figure Taiwan Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Taiwan Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Peptide Cancer Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table Taiwan Peptide Cancer Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table Taiwan Peptide Cancer Vaccine Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Peptide Cancer Vaccine Sales Volume Market Share by Type in 2016
Table Taiwan Peptide Cancer Vaccine Sales Volume (K Pcs) by Applications (2012-2017)
Table Taiwan Peptide Cancer Vaccine Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Peptide Cancer Vaccine Sales Volume Market Share by Application in 2016
Figure India Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Peptide Cancer Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table India Peptide Cancer Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table India Peptide Cancer Vaccine Sales Volume Market Share by Type (2012-2017)
Figure India Peptide Cancer Vaccine Sales Volume Market Share by Type in 2016
Table India Peptide Cancer Vaccine Sales Volume (K Pcs) by Application (2012-2017)
Table India Peptide Cancer Vaccine Sales Volume Market Share by Application (2012-2017)
Figure India Peptide Cancer Vaccine Sales Volume Market Share by Application in 2016
Figure Southeast Asia Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Peptide Cancer Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Peptide Cancer Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Peptide Cancer Vaccine Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Peptide Cancer Vaccine Sales Volume Market Share by Type in 2016
Table Southeast Asia Peptide Cancer Vaccine Sales Volume (K Pcs) by Applications (2012-2017)
Table Southeast Asia Peptide Cancer Vaccine Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Peptide Cancer Vaccine Sales Volume Market Share by Application in 2016
Figure Australia Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Australia Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Peptide Cancer Vaccine Sales Price (USD/Pcs) Trend (2012-2017)
Table Australia Peptide Cancer Vaccine Sales Volume (K Pcs) by Type (2012-2017)
Table Australia Peptide Cancer Vaccine Sales Volume Market Share by Type (2012-2017)
Figure Australia Peptide Cancer Vaccine Sales Volume Market Share by Type in 2016
Table Australia Peptide Cancer Vaccine Sales Volume (K Pcs) by Applications (2012-2017)
Table Australia Peptide Cancer Vaccine Sales Volume Market Share by Application (2012-2017)
Figure Australia Peptide Cancer Vaccine Sales Volume Market Share by Application in 2016
Table Enzo Life Science (Alexis Biotech) Peptide Cancer Vaccine Basic Information List
Table Enzo Life Science (Alexis Biotech) Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Enzo Life Science (Alexis Biotech) Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Enzo Life Science (Alexis Biotech) Peptide Cancer Vaccine Sales Market Share in Asia-Pacific (2012-2017)
Figure Enzo Life Science (Alexis Biotech) Peptide Cancer Vaccine Revenue Market Share in Asia-Pacific (2012-2017)
Table Antigen Express Peptide Cancer Vaccine Basic Information List
Table Antigen Express Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Antigen Express Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Antigen Express Peptide Cancer Vaccine Sales Market Share in Asia-Pacific (2012-2017)
Figure Antigen Express Peptide Cancer Vaccine Revenue Market Share in Asia-Pacific (2012-2017)
Table BioLife Science Peptide Cancer Vaccine Basic Information List
Table BioLife Science Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioLife Science Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure BioLife Science Peptide Cancer Vaccine Sales Market Share in Asia-Pacific (2012-2017)
Figure BioLife Science Peptide Cancer Vaccine Revenue Market Share in Asia-Pacific (2012-2017)
Table Immatics Biotechnologies Peptide Cancer Vaccine Basic Information List
Table Immatics Biotechnologies Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Immatics Biotechnologies Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Immatics Biotechnologies Peptide Cancer Vaccine Sales Market Share in Asia-Pacific (2012-2017)
Figure Immatics Biotechnologies Peptide Cancer Vaccine Revenue Market Share in Asia-Pacific (2012-2017)
Table Immune Design Peptide Cancer Vaccine Basic Information List
Table Immune Design Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Immune Design Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Immune Design Peptide Cancer Vaccine Sales Market Share in Asia-Pacific (2012-2017)
Figure Immune Design Peptide Cancer Vaccine Revenue Market Share in Asia-Pacific (2012-2017)
Table Imugene Peptide Cancer Vaccine Basic Information List
Table Imugene Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Imugene Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Imugene Peptide Cancer Vaccine Sales Market Share in Asia-Pacific (2012-2017)
Figure Imugene Peptide Cancer Vaccine Revenue Market Share in Asia-Pacific (2012-2017)
Table Immunomedics Peptide Cancer Vaccine Basic Information List
Table Immunomedics Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Immunomedics Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Immunomedics Peptide Cancer Vaccine Sales Market Share in Asia-Pacific (2012-2017)
Figure Immunomedics Peptide Cancer Vaccine Revenue Market Share in Asia-Pacific (2012-2017)
Table ISA Pharmaceuticals Peptide Cancer Vaccine Basic Information List
Table ISA Pharmaceuticals Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ISA Pharmaceuticals Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure ISA Pharmaceuticals Peptide Cancer Vaccine Sales Market Share in Asia-Pacific (2012-2017)
Figure ISA Pharmaceuticals Peptide Cancer Vaccine Revenue Market Share in Asia-Pacific (2012-2017)
Table Galena Biopharma Peptide Cancer Vaccine Basic Information List
Table Galena Biopharma Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Galena Biopharma Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Galena Biopharma Peptide Cancer Vaccine Sales Market Share in Asia-Pacific (2012-2017)
Figure Galena Biopharma Peptide Cancer Vaccine Revenue Market Share in Asia-Pacific (2012-2017)
Table Generex Biotechnology Corporation Peptide Cancer Vaccine Basic Information List
Table Generex Biotechnology Corporation Peptide Cancer Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Generex Biotechnology Corporation Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate (2012-2017)
Figure Generex Biotechnology Corporation Peptide Cancer Vaccine Sales Market Share in Asia-Pacific (2012-2017)
Figure Generex Biotechnology Corporation Peptide Cancer Vaccine Revenue Market Share in Asia-Pacific (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Pcs) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Peptide Cancer Vaccine
Figure Manufacturing Process Analysis of Peptide Cancer Vaccine
Figure Peptide Cancer Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Peptide Cancer Vaccine Major Manufacturers in 2016
Table Major Buyers of Peptide Cancer Vaccine
Table Distributors/Traders List
Figure Asia-Pacific Peptide Cancer Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Asia-Pacific Peptide Cancer Vaccine Sales Volume (K Pcs) Forecast by Region (2017-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Peptide Cancer Vaccine Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Revenue Market Share Forecast by Region in 2022
Figure China Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure South Korea Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Taiwan Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Peptide Cancer Vaccine Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Australia Peptide Cancer Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Peptide Cancer Vaccine Sales (K Pcs) Forecast by Type (2017-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Peptide Cancer Vaccine Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Peptide Cancer Vaccine Price (USD/Pcs) Forecast by Type (2017-2022)
Table Asia-Pacific Peptide Cancer Vaccine Sales (K Pcs) Forecast by Application (2017-2022)
Figure Asia-Pacific Peptide Cancer Vaccine Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories